NFKB1 and Hypertension: In a rat model of hypertension, increased activity of matrix metalloproteinase indicated the hyper activation of NF-κB [137], thus suggesting that inhibition of the NF-κB cascade by anti-inflammatory drugs may be a promising target for the treatment of ischemia-reperfusion injury.